Lonza Group AG (LON:0QNO)
585.62
+9.18 (1.59%)
At close: Oct 24, 2025
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of 38.94 billion as of October 24, 2025. Its market cap has increased by 14.56% in one year.
Market Cap
38.94B
Enterprise Value
42.50B
Revenue
6.51B
Ranking
n/a
PE Ratio
57.89
Stock Price
585.62
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 2.30B to 38.94B, an increase of 1,590.23%. That is a compound annual growth rate of 11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 38.94B | 14.21% |
| Dec 30, 2024 | 34.10B | 39.19% |
| Dec 29, 2023 | 24.50B | -18.81% |
| Dec 30, 2022 | 30.17B | -34.20% |
| Dec 30, 2021 | 45.85B | 30.36% |
| Dec 30, 2020 | 35.17B | 70.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 66.21B |
| Haleon | 31.28B |
| Smith & Nephew | 11.67B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.71B |